Basal-like breast tumors are preferentially low in ER and HER2 expression, and are significantly associated with several basal cytokeratin (CK) markers, including CK 5/6, CK 14, CK 17, and epidermal growth factor receptor (EGFR) [11]. The gene discussed is ERBB2; the disease is breast neoplasm.